Loading...
Chronic hepatitis B: What should be the goal for new therapies?
Chronic hepatitis B can currently be medically managed with either pegylated interferon-alpha (pegIFN-α) or one of the five nucleos(t)ide analogue Direct Acting Antivirals (DAAs) that inhibit the hepatitis B virus (HBV) DNA polymerase. While pegIFN-α is effective in approximately one-third of the tr...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3627746/ https://ncbi.nlm.nih.gov/pubmed/23391846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2013.01.006 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|